Geode Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $56.1M | Buy |
|
|||||
|
2025
Q2 | $37.9M | Buy |
|
|||||
|
2025
Q1 | $44.5M | Buy |
|
|||||
|
2024
Q4 | $46.5M | Buy |
|
|||||
|
2024
Q3 | $27.5M | Buy |
|
|||||
|
2024
Q2 | $21M | Buy |
|
|||||
|
2024
Q1 | $22.9M | Buy |
|
|||||
|
2023
Q4 | $12.3M | Buy |
|
|||||
|
2023
Q3 | $9.35M | Buy |
|
|||||
|
2023
Q2 | $8.04M | Buy |
|
|||||
|
2023
Q1 | $4.39M | Buy |
|
|||||
|
2022
Q4 | $5M | Buy |
|
|||||
|
2022
Q3 | $5.64M | Buy |
|
|||||
|
2022
Q2 | $3.88M | Buy |
|
|||||
|
2022
Q1 | $2.2M | Buy |
|
|||||
|
2021
Q4 | $2.83M | Buy |
|
|||||
|
2021
Q3 | $2.67M | Sell |
|
|||||
|
2021
Q2 | $3.64M | Buy |
|
|||||
|
2021
Q1 | $3.28M | Sell |
|
|||||
|
2020
Q4 | $4.56M | Buy |
|